This blog was written by Julia Hamer-Hunt, patient co-chair of the Oxford Health BRC’s strategic patient and public involvement (PPI) group and Claire Murray, PPI Manager. It was originally published…
A new study has reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza.
A new study shows 1 in 3 survivors of COVID-19 received a neurological or psychiatric diagnosis within 6 months. The risk was greater in people who had severe COVID-19, but 1 in 9 patients not requiring hospitalization, also received a diagnosis.
Virtual YPAG session March 2021Written by Vanessa BennettReviewed and edited by Caitlin Brookes and Amelia Crook (NeurOX YPAG members) This was an opportunity for our remaining ‘long-standing’ members to reflect…
